Should Routine Colon Cancer Screening Start at 45, Not 50? Should Routine Colon Cancer Screening Start at 45, Not 50?
The increase in colorectal cancer among younger adults has led to debate about lowering the age at which to begin screening.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 18, 2020 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Adding Cetuximab to Chemo Curbs Survival in Resectable Colorectal Liver Metastasis Adding Cetuximab to Chemo Curbs Survival in Resectable Colorectal Liver Metastasis
The combination of chemotherapy and the epidermal-growth-factor receptor (EGFR) antibody cetuximab shortens survival compared with chemotherapy alone in certain patients with colorectal cancer, according to an open-label randomized trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 18, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

First Robot for Supermicrosurgery, Used for Lymphedema First Robot for Supermicrosurgery, Used for Lymphedema
The first pilot study of robot-assisted high-precision supermicrosurgery in humans shows it is safe for treating breast cancer-related lymphedema.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Screen for Cervical Cancer Every 3 Years: More Is a'Waste'Screen for Cervical Cancer Every 3 Years: More Is a'Waste '
Screening every 3 years is as safe and effective, significantly reducing the rate of cervical cancer; more frequent screening wastes healthcare resources.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Incredible' Results With Kidney Cancer Agent With Nobel Ties'Incredible' Results With Kidney Cancer Agent With Nobel Ties
Once thought to be"undruggable," a target in renal cell carcinoma now has a drug aimed at it, and initial results from a small clinical trial are promising.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncologists Are Average in Terms of Happiness, Survey Suggests Oncologists Are Average in Terms of Happiness, Survey Suggests
In the survey, 32% of oncologists reported experiencing burnout, 29% said they were very or extremely happy at work, and only 51% said they were very or extremely happy outside of work.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 17, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Failed Strategy for an Effective Bladder Cancer Drug A Failed Strategy for an Effective Bladder Cancer Drug
When the number of doses of BCG for high-grade non-muscle invasive bladder cancer was cut, outcomes were inferior in a randomized clinical trial.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - February 17, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

The Effects of GM1 in Taxane-Induced Neurotoxicity The Effects of GM1 in Taxane-Induced Neurotoxicity
Might ganglioside-monosialic acid help prevent the neurotoxic effects of taxane chemotherapy in breast cancer patients?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 17, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

GI Bleeding on Oral Anticoagulants in AF Foremost a Cancer Red Flag GI Bleeding on Oral Anticoagulants in AF Foremost a Cancer Red Flag
An observational study'is a wake-up call for us to not let any kind of bleed in the GI tract go without a more detailed investigation for potential cancer,'says an expert observer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2020 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Transgender Breast Screening Information Hard to Find Transgender Breast Screening Information Hard to Find
At a time when a growing number of transgender Americans are getting gender-affirming treatments to make their bodies match their identity, breast imaging centers may not be changing to meet their needs.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A Rare QoL Study That Could Change Practice A Rare QoL Study That Could Change Practice
Two drugs comparably improve survival in the treatment of men with hormone-sensitive prostate cancer, so researchers looked at quality of life to see whether that was a difference maker.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU Restricts High-Dose Cyproterone Because of Meningioma Risk EU Restricts High-Dose Cyproterone Because of Meningioma Risk
Products containing the antiandrogen cyproterone with daily doses of 10 mg or more should be restricted because of a risk of meningioma.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

' Different Flavors' of Gene Editing Moving Closer to Your Clinic'Different Flavors' of Gene Editing Moving Closer to Your Clinic
' Keep your ears and eyes open because it's a very optimistic time'for gene editing technologies like CRISPR, say Drs Caron Jacobson and Cathy Wu.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

More Than 50 Polyps in Some Young Cancer Survivors More Than 50 Polyps in Some Young Cancer Survivors
Pediatric and young adult cancer patients are at risk of developing numerous polyps (for some, more than 50 polyps) as a result of prior cancer treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 13, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' My Son Didn't Recognize Me': The Rootless Life of Medical Trainees'My Son Didn't Recognize Me': The Rootless Life of Medical Trainees
The constant moving inherent in today's medical education alienates young doctors from their families, patients, and communities.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 13, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Hard Times for America's $100M Breast Cancer Screening Trial Hard Times for America's $100M Breast Cancer Screening Trial
The United States is spending a lot of money on a huge breast cancer screening trial that some clinicians say is unnecessary or even unethical. What's going on?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 13, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Circulating Tumor Cells May Predict Melanoma Relapse Circulating Tumor Cells May Predict Melanoma Relapse
In patients with stage III melanoma, levels of circulating tumor cells (CTCs) may predict relapse, potentially allowing for identification of individuals who could benefit from close surveillance or adjuvant therapy, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Refinement of Surgical Treatment' Is ASCO Advance of the Year'Refinement of Surgical Treatment' Is ASCO Advance of the Year
New systemic therapies have changed the role of surgery in several cancer tumor types, even eliminating the need for it in some cases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 12, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Despite Scandals, Conflict Disclosures Remain Challenging Despite Scandals, Conflict Disclosures Remain Challenging
What, exactly, is conflict of interest? Three leading physicians tackle the definition and management of this extremely complicated--and prevalent--issue.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Adding Ilixadencel Improved Outcomes in Metastatic RCC Adding Ilixadencel Improved Outcomes in Metastatic RCC
Combining intratumoral injections of ilixadencel with sunitinib improved responses in patients with newly diagnosed synchronous metastatic renal cell carcinoma in the phase 2 MERECA trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Glioma Trials Should Track Living Well, Not Just Longer Glioma Trials Should Track Living Well, Not Just Longer
Neuro-oncology working group backs focus on how patients feel, function.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Watch & Wait' in Rectal Cancer Doesn't Compromise Outcomes'Watch & Wait' in Rectal Cancer Doesn't Compromise Outcomes
Another study adds support for taking a watch-and-wait (W&W) approach for patients with low rectal tumors instead of recommending immediate surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Glaring Gap in CV Event Reporting in Pivotal Cancer Trials Glaring Gap in CV Event Reporting in Pivotal Cancer Trials
A provocative new study points to serious shortcomings in the reporting and recognition of cardiovascular events in contemporary cancer therapy trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2020 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

' Important Conversations' About Cannabis With Cancer Patients'Important Conversations' About Cannabis With Cancer Patients
Cancer patients are increasingly trying, and asking about, cannabis and cannabinoids. These are'important conversations'for clinicians to be having.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Japan's Halt of Regular HPV Vaccine to Cause Thousands of Cancer Deaths - Study Japan's Halt of Regular HPV Vaccine to Cause Thousands of Cancer Deaths - Study
A decision by Japan to stop recommending adolescent girls receive a HPV vaccination will likely result in almost 11,000 deaths from cervical cancer if it is not reversed, according to a study published on Monday.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 11, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Updated Staging Manual Better Predicts Outcomes of Melanoma Updated Staging Manual Better Predicts Outcomes of Melanoma
The eighth edition of the American Joint Committee on Cancer staging manual (AJCC8) outperforms the previous AJCC7 in predicting relapse-free survival (RFS) and overall survival (OS) in patients with melanoma, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Smartphone Apps for Suspicious Skin Lesions Unreliable Smartphone Apps for Suspicious Skin Lesions Unreliable
Smartphone apps marketed to the general public for use on suspicious skin lesions are unreliable, as they may miss melanoma, concludes a review.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Janssen Announces Submission to U.S. FDA for New DARZALEX ® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma
RARITAN, NJ, February 10, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexamethasone (DKd) for relapsed/refractory multiple myeloma. The sBLA is supported by results from the Phase 3 CANDOR study, which compared treatment with DKd to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who relapsed after one to three prior lines of therapy. “W...
Source: Johnson and Johnson - February 10, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

ctDNA for Tracking Minimal Residual Disease in Colon Cancer ctDNA for Tracking Minimal Residual Disease in Colon Cancer
Find out about the potential role of plasma circulating-tumor DNA in determining minimal residual disease in patients with localized colon cancer.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 10, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

' Milestone' Catalogue of Mutations in the Cancer Genome'Milestone' Catalogue of Mutations in the Cancer Genome
An international mammoth collaboration has catalogued mutations in the coding and noncoding regions of more than 2600 genomes from 38 different tumor types. But it is not yet available for clinical use.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

For Patients on Blood Thinners, GI Bleeding May Signal Colon Cancer: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 7, 2020 Category: Cancer & Oncology Tags: Cardiology, Gastroenterology, Hematology, Oncology, News, Source Type: news

Stopping Smoking Allows Healthy Lung Cells to Proliferate Stopping Smoking Allows Healthy Lung Cells to Proliferate
Healthy cells that have a low mutational burden may proliferate after people quit smoking, which could reduce the risk of developing cancer, say researchers.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

U.S. Government Experts, Industry Spar Over Asbestos Testing in Talc U.S. Government Experts, Industry Spar Over Asbestos Testing in Talc
Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 6, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Uptick in Lung Cancer in Younger Women, Not Related to Smoking Uptick in Lung Cancer in Younger Women, Not Related to Smoking
New data on lung cancer in younger adults ( (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Genomic Profiling for Patients With Metastatic Colon Cancer Genomic Profiling for Patients With Metastatic Colon Cancer
Genomic testing can identify biomarkers that may help guide treatment decisions in metastatic colon cancer, but are patients receiving these tests according to recommended guidelines?JCO Precision Oncology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 6, 2020 Category: Pathology Tags: Hematology-Oncology Journal Article Source Type: news

' Groundbreaking' Cancer Drug Recycling at Major US Center'Groundbreaking' Cancer Drug Recycling at Major US Center
Cancer drug recycling allows unused pills to be given to needy patients. A new program in Ohio adds a helpful new twist to the effort.Medscape Medical News (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - February 5, 2020 Category: Nursing Tags: Hematology-Oncology News Source Type: news

De-escalation of Cancer Treatment: When Is Less Really More? De-escalation of Cancer Treatment: When Is Less Really More?
' We've gotten very comfortable overtreating people,'says Dr Kathy Miller. Listen in as she and Dr Eric Winer discuss the controversial concept of de-escalating therapy for breast cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2020 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Distinct Features of Thin Nodular Primary Melanomas Distinct Features of Thin Nodular Primary Melanomas
What could the clinical and histological characteristics of thin nodular melanomas tell us about patient prognosis?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Time to Stop the'Victory Bell' at End of Cancer Treatment? Time to Stop the'Victory Bell' at End of Cancer Treatment?
Many hospitals have a'victory bell'that patients can ring in triumph at the end of cancer treatment, but new data suggest that it can make patients feel worse, not better.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

CT Signature Predicts Survival, Chemotherapy Benefit in Gastric Cancer CT Signature Predicts Survival, Chemotherapy Benefit in Gastric Cancer
A deep-learning signature based on preoperative CT images predicts survival and the benefit of adjuvant chemotherapy in patients with gastric cancer, researchers report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 5, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Patient-Reported Outcomes in Cancer Trials to Be Standardized Patient-Reported Outcomes in Cancer Trials to Be Standardized
Recommendations have been made to standardize patient-reported outcomes in cancer trials to ensure that quality-of-life results reflect the real benefits and risks for treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

World Cancer Day Survey Exposes'Glaring Inequities'World Cancer Day Survey Exposes'Glaring Inequities '
No matter where they live in the world, people with low socioeconomic status and/or low education are unaware of many cancer risks --'information that many of us take for granted. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Invasive Colorectal Cancers by Age 50 Bolster Case for Earlier Screening Invasive Colorectal Cancers by Age 50 Bolster Case for Earlier Screening
The vast majority of colorectal cancers detected in 50-year-olds - when screening usually begins - turn out to be invasive, suggesting screening should start earlier, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Phase I Trial Aims to Evaluate Cobomarsen in Certain Hematologic Malignancies
The phase I trial is evaluating cobomarsen in cancers where the disease process appears to be correlated with an increase in miR-155 levels, including adult T-cell leukemia/lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia. (Source: CancerNetwork)
Source: CancerNetwork - February 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

' How Long Do I Have?' New Online Tool for Patients With Cancer'How Long Do I Have?' New Online Tool for Patients With Cancer
Oncologists approached by Medscape had positive reactions to a new online prognosis tool for patients that was launched late last year.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 3, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Oncologist Confidential: I Pray With My Patients Oncologist Confidential: I Pray With My Patients
' It has been, universally, very uplifting for the patient, their family, and me. It's such a special thing to be able to do. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 3, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

US Cancer Centers Embroiled in Chinese Research Thefts US Cancer Centers Embroiled in Chinese Research Thefts
Ongoing investigations have already led to an airport arrest of a researcher smuggling biological samples and to the firing of top executives at the Moffitt Cancer Center.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 3, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

January 2020 Briefing - Hematology & amp; Oncology
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2020 Category: Cancer & Oncology Tags: Oncology, Monthly Briefing, Source Type: news

Consensus on Management of EGFR-Mutant Lung Cancer Consensus on Management of EGFR-Mutant Lung Cancer
Consensus-based recommendations from the Society for Translational Medicine addresses the management of EGFR-mutated lung cancer.Translational Lung Cancer Research (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 3, 2020 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news